Skip to main content
. 2020 Sep 1;16:2127–2135. doi: 10.3762/bjoc.16.180

Figure 1.

Figure 1

Evaluation of GlypNirO site-specific N-glycosylation profiling. Site-specific relative glycoform abundance in HCC and healthy controls at (a) immunoglobulin heavy constant gamma 1 (IgG1) N180, and (b) alpha-1-antichymotrypsin N106 and N271.